4//SEC Filing
AGILE THERAPEUTICS INC 4
Accession 0001104659-17-032106
CIK 0001261249operating
Filed
May 11, 8:00 PM ET
Accepted
May 12, 7:59 AM ET
Size
4.9 KB
Accession
0001104659-17-032106
Insider Transaction Report
Form 4
Selman Renee
Chief Commercial Officer
Transactions
- Purchase
Common Stock
2017-05-11$3.68/sh+53,333$196,265→ 53,333 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $3.46 to $3.75, inclusive. The reporting person undertakes to provide to Agile Therapeutics, Inc., any security holder of Agile Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
AGILE THERAPEUTICS INC
CIK 0001261249
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001261249
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 7:59 AM ET
- Size
- 4.9 KB